Dr. Eduardo de Pablo-Fernández speaks with Dr. Dilan Athauda about his recent paper, «The impact of type 2 diabetes in Parkinson’s disease» recently published in Movement Disorders. They discuss the clinical impact of type 2 diabetes in the phenotype and disease progression and the therapeutic implications of this association. Read the article.